Glutamic Acid

Glutamic Acid

SCHEMBL175044

ClCc1ccc2c(c1)CCNCC2.N[C@@H](CCC(=O)O)C(=O)O

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIK1 P39086 2/20 0.43
GRIA1 P42261 2/20 0.43
GRIA2 P42262 2/20 0.43
GRIA3 P42263 2/20 0.43
GRIA4 P48058 2/20 0.43
GRIK2 Q13002 2/20 0.43
GRIK3 Q13003 2/20 0.43
GRM8 O00222 1/20 0.43
GRM6 O15303 1/20 0.43
GRIN2D O15399 1/20 0.43
GRIN3B O60391 1/20 0.43
GSR P00390 1/20 0.43
CYP1A2 P05177 1/20 0.43
GRM5 P41594 1/20 0.43
SLC1A3 P43003 1/20 0.43
SLC1A2 P43004 1/20 0.43
SLC1A1 P43005 1/20 0.43
GRIN1 Q05586 1/20 0.43
GRIN2A Q12879 1/20 0.43
GRIN2B Q13224 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Aspartic Acid SCHEMBL175033 0.88 MLNR (0.39) GRIK1GRIA1GRIA2GRIA4GRIK3
Succinic Acid SCHEMBL174914 0.86 HTR2C (0.45) ACHEMLNRHTR2AHTR2CHTR2B
Adipic Acid SCHEMBL173690 0.83 HTR2C (0.42) ACHEMLNRHTR2AHTR2CHTR2B
Malonic Acid SCHEMBL173339 0.81 HTR2C (0.45) ACHEMLNRHTR2AHTR2CHTR2B
Glycolic Acid SCHEMBL174349 0.81 HTR2C (0.45) ACHEMLNRHTR2AHTR2CHTR2B
Alpha-Ketoglutaric Acid SCHEMBL174620 0.80 MLNR (0.43) ACHEMLNRHTR2AHTR2CHTR2B
SCHEMBL162032 0.77 HTR2C (0.57) MLNRHTR2AHTR2CHTR2BCYP2D6
Bromide SCHEMBL174563 0.76 HTR2C (0.55) MLNRHTR2AHTR2CHTR2BCYP2D6
Glutamic Acid SCHEMBL161669 0.75 GRM8 (0.39) GRIK1GRIA1GRIA2GRIA3GRIA4
Glutamic Acid SCHEMBL158772 0.75 GRM8 (0.39) GRIK1GRIA1GRIA2GRIA3GRIA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2611449-A1 ADMINISTRATION OF LORCASERIN TO INDIVIDUALS WITH RENAL IMPAIRMENT Arena Pharmaceuticals, Inc. (US) 2013-07-10 EP disclosed
EP-2611427-A2 MODIFIED-RELEASE DOSAGE FORMS OF 5-HT2C AGONISTS USEFUL FOR WEIGHT MANAGEMENT& xA; Arena Pharmaceuticals, Inc. (US) 2013-07-10 EP disclosed
WO-2012030927-A2 MODIFIED-RELEASE DOSAGE FORMS OF 5-HT2C AGONISTS USEFUL FOR WEIGHT MANAGEMENT ARENA PHARMACEUTICALS, INC. (US) 2012-03-08 WO disclosed
WO-2012030939-A1 ADMINISTRATION OF LORCASERIN TO INDIVIDUALS WITH RENAL IMPAIRMENT ARENA PHARMACEUTICALS, INC. (US) 2012-03-08 WO disclosed